# Task C1D1: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Antibiotic-Resistant Tuberculosis

> **NIH NIH N01** · ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC. · 2024 · $59,004

## Abstract

The Early Phase Clinical Trial Units provide a vehicle for investigation of new agents in the treatment and prevention of infectious diseases and can carry out all aspects of interventional clinical trial implementation.

## Key facts

- **NIH application ID:** 11166262
- **Project number:** 75N93022D00018-P00002-759302300001-1
- **Recipient organization:** ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
- **Principal Investigator:** ROBERT SPITZ
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $59,004
- **Award type:** —
- **Project period:** 2023-07-05 → 2025-07-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11166262

## Citation

> US National Institutes of Health, RePORTER application 11166262, Task C1D1: A Study to Evaluate the Pharmacokinetics and Safety of a Therapeutic for Antibiotic-Resistant Tuberculosis (75N93022D00018-P00002-759302300001-1). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/11166262. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*